Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
You cant eat or sleep like you can at home, where you have your own bed, bathroom, things like that
Some people stopped taking orforglipron because of side effects, with higher doses leading to higher rates of discontinuation
12 , e2410937 (2025)
Retatrutide is a new weight loss drug from Eli Lilly and has promising results in clinical trials but is not yet available
Patients switching from tirzepatide to semaglutide should expect somewhat reduced appetite suppression and potentially slower weight loss, given that they are moving from a dual agonist to a single agonist
What this means in practice For clinicians: the July PCAC timeline gives three months to do the infrastructure work
